Symbiotec Pharmalab IPO Allotment Status Online Check On MUFG Intime 2026

Symbiotec Pharmalab IPO allotment status will be done on August 28, 2026, and investors whose bids are not completed, their money will be refunded on August 31, 2026.

Symbiotec Pharmalab IPO total subscribed 75.08x so far, with QIB subscribed 181.20x, NII subscribed 77.56x and retail investors subscribed 13.69x, and employee subscribed 16.32x. Symbiotec Pharmalab IPO Subscription to all Got good subscription in the all category.

Read Also: Symbiotec Pharmalab IPO GMP

Symbiotec Pharmalab IPO Allotment Status Online

Investors who have subscribed to the Symbiotec Pharmalab IPO can check the allotment status by visiting the official website of MUFG Intime Private Limited, the registrar of this Symbiotec Pharmalab IPO.

To check the Symbiotec Pharmalab IPO allotment status, follow the steps below…

1. Click on the above allotment status check button.
2. Select Company Name.
3. Enter your (Anyone Proof) PAN Number, Application Number or DP Client ID to check your ipo allotment status.
4. Click on Search.

Below the button to check Symbiotec Pharmalab IPO allotment status online.

Allotment Process

1. Subscription Period Closes: Once the IPO subscription window ends, the company or its registrar begins the allotment process.
2. Oversubscription Handling: If the IPO is oversubscribed, the shares are allocated either on a lottery basis or a pro-rata allocation method.
3. Allotment Announcement: After the allotment process, the registrar will announce the IPO allotment status through the official website of the registrar, BSE, NSE, or the company’s website.
4. Refund Process: If an investor is not allotted any shares or receives partial allotment, the remaining application amount is refunded. The refund is credited to the investor’s bank account.
5. Shares Credited to Demat Account: If the investor is allotted shares, the shares are credited to their Demat account before the listing date.

Importance of IPO Allotment Status

The IPO allotment status provides critical information to investors regarding their application. It helps investors understand:

1. Share Allocation: It determines whether they have received the number of shares they applied for or if their application has been rejected.
2. Investment Decisions: The status also allows investors to decide if they want to participate in the listing or exit before the shares are listed on the stock exchanges.
3. Refund Details: If shares are not allotted, the status also gives investors the details regarding the refund of their application amount.

Symbiotec Pharmalab IPO FAQs

Thank You…